Clearside Biomedical Inc reports results for the quarter ended in June - Earnings Summary

Clearside Biomedical,

14/08/2023 22:45

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 15 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 14 cents per share.
    * Revenue rose 165.1% to $1.02 million from a year ago;
analysts
expected $124.20 thousand. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 15 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearside Biomedical Inc shares had fallen by 6.3% this
quarter.
    * The company reported a quarterly loss of $9.11 million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $5.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:45 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.14          -0.15          Missed
 Mar. 31 2023      -0.14          -0.15          Missed
 Dec. 31 2022      -0.13          -0.16          Missed
 Sep. 30 2022      -0.03          -0.13          Missed